TNFRSF17 and Miyoshi myopathy: Similarly, within the domain of multiple myeloma (MM), a significant contingent of patients exhibited a discernible downregulation of B cell maturation antigen (BCMA) subsequent to therapeutic interventions centered on BCMA-targeting CAR-T strategies [16, 17].